Organisation paid for research Program year 2022 Source: CMS Open Payments

JTF Consulting LLC

Neither a doctor nor a teaching hospital

Research payments

$72,855

30 payments

Through program year 2022, JTF Consulting LLC is reported as receiving $72,855 in research payments, across 30 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$675	1
2021	Research	$2,520	1
2020	Research	$17,050	9
2019	Research	$52,610	19

Breakdown

Who paid Research payments · program years 2019–2022

Hoffmann-La Roche Limited $52,925 20 payments
Novartis Pharmaceuticals Corporation $17,460 3 payments
AbbVie, Inc. $2,470 7 payments

Studies the money was for Research payments · program years 2019–2022

A Phase III Study in Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Brafwt Melanoma Patients $46,220 13 payments
A Randomized Double Blind Placebo Controlled Phase II Study of Everolimus in Combination With Exemestane in the Treatment of Chinese Postmenopausal Women With Estrogen Receptor Positive Her-2 Negative Locally Advanced Recurrent Or Metastatic Breast Cancer $14,940 2 payments
A Phase 1B Study Evaluating the Efficacy Safety of Atezolizumab and Cotellic in 2L Brafwt Melanoma $6,705 7 payments
A Randomized Double Blind Placebo Controlled Phase II Study of Everolimus in Combination With Exemestane in the Treatment of Chinese Postmenopausal Women With Estrogen Receptor Positive Her-2 Negative Locally Advanced Recurrent Or Metastatic Breast Cancer After Recurrence Or Progression on Prior Letrozole Or Anastrozole $2,520 1 payment
M12-914 $1,980 6 payments
M12-895 $490 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.